Detalles de la búsqueda
1.
Hollow-fibre system model of tuberculosis reproducibility and performance specifications for best practice in drug and combination therapy development.
J Antimicrob Chemother
; 78(4): 953-964, 2023 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36794692
2.
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
Alzheimers Dement
; 19(2): 696-707, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35946590
3.
Sputum lipoarabinomannan (LAM) as a biomarker to determine sputum mycobacterial load: exploratory and model-based analyses of integrated data from four cohorts.
BMC Infect Dis
; 22(1): 327, 2022 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35366820
4.
Duration of pretomanid/moxifloxacin/pyrazinamide therapy compared with standard therapy based on time-to-extinction mathematics.
J Antimicrob Chemother
; 75(2): 392-399, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31713607
5.
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement.
Am J Transplant
; 19(3): 625-632, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30549395
6.
Recommendations for the design of therapeutic trials for neonatal seizures.
Pediatr Res
; 85(7): 943-954, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30584262
7.
Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy.
J Pharmacokinet Pharmacodyn
; 46(5): 441-455, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31127458
8.
Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug development.
J Pharmacokinet Pharmacodyn
; 45(3): 457-467, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29520534
9.
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug Development.
Antimicrob Agents Chemother
; 60(3): 1177-82, 2016 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26824941
10.
Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation.
Alzheimers Dement
; 12(9): 1022-1030, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27327540
11.
Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge.
Alzheimers Dement
; 12(9): 1014-1021, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27238630
12.
Nonclinical models for antituberculosis drug development: a landscape analysis.
J Infect Dis
; 211 Suppl 3: S83-95, 2015 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26009617
13.
Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool.
Clin Infect Dis
; 61 Suppl 1: S5-9, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26224771
14.
Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments.
Clin Infect Dis
; 61 Suppl 1: S10-7, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26224767
15.
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.
Clin Infect Dis
; 61 Suppl 1: S18-24, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26224768
16.
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.
Clin Infect Dis
; 61 Suppl 1: S25-31, 2015 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26224769
17.
Development of a unified clinical trial database for Alzheimer's disease.
Alzheimers Dement
; 11(10): 1212-21, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25676387
18.
Elements for adequate informed consent in the surgical context.
World J Surg
; 38(7): 1594-604, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24803343
19.
Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmias.
Qual Life Res
; 23(1): 129-34, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23748905
20.
Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-Path-ISOP 2013 workshop.
J Pharmacokinet Pharmacodyn
; 41(6): 545-52, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25288257